Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Operating Leases: 2019-2024

Historic Operating Leases for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $107,000.

  • Eton Pharmaceuticals' Operating Leases rose 280.95% to $480,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $480,000, marking a year-over-year increase of 280.95%. This contributed to the annual value of $107,000 for FY2024, which is 386.36% up from last year.
  • Per Eton Pharmaceuticals' latest filing, its Operating Leases stood at $107,000 for FY2024, which was up 386.36% from $22,000 recorded in FY2023.
  • Eton Pharmaceuticals' Operating Leases' 5-year high stood at $107,000 during FY2022, with a 5-year trough of $15,000 in FY2021.
  • For the 3-year period, Eton Pharmaceuticals' Operating Leases averaged around $78,667, with its median value being $107,000 (2024).
  • Per our database at Business Quant, Eton Pharmaceuticals' Operating Leases crashed by 84.85% in 2021 and then soared by 613.33% in 2022.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Operating Leases stood at $99,000 in 2020, then plummeted by 84.85% to $15,000 in 2021, then spiked by 613.33% to $107,000 in 2022, then crashed by 79.44% to $22,000 in 2023, then surged by 386.36% to $107,000 in 2024.